Deferasirox drives ROS-mediated differentiation and induces interferon-stimulated gene expression in human healthy haematopoietic stem/progenitor cells and in leukemia cells

BACKGROUND: Administration of the iron chelator deferasirox (DFX) in transfusion-dependent patients occasionally results in haematopoiesis recovery by a mechanism remaining elusive. This study aimed to investigate at a molecular level a general mechanism underlying DFX beneficial effects on haematop...

Descripció completa

Guardat en:
Dades bibliogràfiques
Publicat a:Stem Cell Res Ther
Autors principals: Tataranni, Tiziana, Mazzoccoli, Carmela, Agriesti, Francesca, De Luca, Luciana, Laurenzana, Ilaria, Simeon, Vittorio, Ruggieri, Vitalba, Pacelli, Consiglia, Della Sala, Gerardo, Musto, Pellegrino, Capitanio, Nazzareno, Piccoli, Claudia
Format: Artigo
Idioma:Inglês
Publicat: BioMed Central 2019
Matèries:
Research
Accés en línia:https://ncbi.nlm.nih.gov/pmc/articles/PMC6567456/
https://ncbi.nlm.nih.gov/pubmed/31196186
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/s13287-019-1293-y
Etiquetes: Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!

Ítems similars